# Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema

> **NCT00826618** · PHASE1 · COMPLETED · sponsor: **University of Miami** · enrollment: 6 (actual)

## Conditions studied

- Uveitic Cystoid Macular Edema

## Interventions

- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT00826618
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2012-09
- **Final completion:** 2013-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2014-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00826618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00826618, "Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00826618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*